Free Trial
→ Your book is inside (From Profits Run) (Ad)tc pixel Free LXEO Stock Alerts

Lexeo Therapeutics (LXEO) Short Interest Ratio & Short Volume

Lexeo Therapeutics logo
$4.24 +0.03 (+0.71%)
Closing price 04:00 PM Eastern
Extended Trading
$4.13 -0.11 (-2.69%)
As of 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

Lexeo Therapeutics Short Interest Overview

As of May 29, 2026, Lexeo Therapeutics (LXEO) had a short interest of 13.78 million shares sold short, representing 18.53% of the public float. This marks a 4.26% increase in short interest since the prior report. The short interest ratio (days to cover) is 17.4, meaning it would take 17.4 days of the average trading volume of 721,318 shares to cover all short positions.

Current Short Interest
13,775,211 shares
Previous Short Interest
13,212,896 shares
Change Vs. Previous Month
4.26%
Dollar Volume Sold Short
$70.80 million
Short Interest Ratio
17.4 Days to Cover
Last Record Date
May 29, 2026
Outstanding Shares
78,520,000 shares
Short Percent of Float
18.53%
Today's Trading Volume
437,809 shares
Average Trading Volume
721,318 shares
Today's Volume Vs. Average
61%
Short Selling Lexeo Therapeutics?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for Lexeo Therapeutics and its competitors with MarketBeat's FREE newsletter.

Get Report
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

LXEO Short Interest Over Time

LXEO Days to Cover Over Time

LXEO Percentage of Float Shorted Over Time

Lexeo Therapeutics Tesla Short Interest History & Recent Changes

Export
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
5/29/202613,775,211 shares $70.80 million +4.3%18.5%17.36 $5.14
5/15/202613,212,896 shares $67.25 million +1.1%17.8%18.82 $5.09
4/30/202613,065,123 shares $74.47 million +3.7%17.6%18.92 $5.70
4/15/202612,604,284 shares $85.71 million +0.9%18.0%9.87 $6.80
3/31/202612,497,266 shares $71.73 million +5.9%17.8%14.14 $5.74
3/13/202611,797,859 shares $78.57 million +6.0%17.1%11.36 $6.66
2/27/202611,125,688 shares $79.88 million -2.9%16.1%19.05 $7.18
2/13/202611,459,188 shares $72.31 million -4.3%16.6%12.83 $6.31
1/30/202611,976,055 shares $88.74 million +4.5%17.3%14.55 $7.41
1/15/202611,456,768 shares $85.93 million +5.8%16.6%6.85 $7.50
12/31/202510,830,747 shares $107.55 million +52.5%15.7%5.85 $9.93
12/15/20257,101,931 shares $69.31 million +17.6%10.3%7.21 $9.76
11/28/20256,037,215 shares $59.37 million +7.1%8.7%5.76 $9.83
11/14/20255,636,938 shares $50.96 million +8.8%8.2%3.44 $9.04
10/31/20255,183,029 shares $51.88 million -29.2%10.1%3.97 $10.01
10/15/20257,320,000 shares $64.64 million +22.8%17.2%8.9 $8.83
9/30/20255,960,000 shares $39.57 million +1.2%14.0%9 $6.64
9/15/20255,890,000 shares $31.69 million +12.6%13.8%11.4 $5.38
8/31/20255,230,000 shares $25.05 million -1.0%11.2%11.6 $4.79
8/15/20255,280,000 shares $24.92 million +0.6%12.1%10.2 $4.72
7/31/20255,250,000 shares $24.83 million +1.4%22.9%8.5 $4.73
7/15/20255,180,000 shares $21.34 million +0.6%22.6%7.3 $4.12
6/30/20255,150,000 shares $20.70 million +7.7%22.5%5.7 $4.02
6/15/20254,780,000 shares $18.83 million +26.5%19.1%4.7 $3.94
5/31/20253,780,000 shares $10.43 million +21.5%15.1%3.8 $2.76
5/15/20253,110,000 shares $8.40 million -4.6%12.4%3.2 $2.70
4/30/20253,260,000 shares $12.81 million +10.9%13.0%3.7 $3.93
4/15/20252,940,000 shares $7.50 million +14.0%11.8%4 $2.55
3/31/20252,580,000 shares $8.95 million +16.2%10.3%3.9 $3.47
3/15/20252,220,000 shares $6.82 million -8.6%8.9%4.8 $3.07
2/28/20252,430,000 shares $6.95 million +5.2%9.8%7.5 $2.86
2/15/20252,310,000 shares $10.40 million +22.9%9.2%9 $4.50
1/31/20251,880,000 shares $10.21 million -18.6%8.0%5.3 $5.43
1/15/20252,310,000 shares $12.68 million +3.1%9.8%6.3 $5.49
12/31/20242,240,000 shares $14.74 million +9.3%9.4%5.9 $6.58
12/15/20242,050,000 shares $14.10 million -6.8%8.6%5.2 $6.88
11/30/20242,200,000 shares $18.11 million -11.7%9.2%5.1 $8.23
11/15/20242,490,000 shares $16.56 million +13.7%10.5%6.1 $6.65
10/31/20242,190,000 shares $17.30 million +6.3%9.8%7.6 $7.90
10/15/20242,060,000 shares $18.40 million -0.5%9.4%6.9 $8.93
Before you buy SpaceX shares, consider this alternative approach (Ad)

SpaceX has confidentially filed for an IPO with the SEC, targeting a June 2026 listing at a valuation exceeding $1.75 trillion - potentially the largest IPO in history. But one expert says buying shares directly may not be the smartest move. There is a lesser-known way to tap into this windfall that most investors haven't considered.tc pixel

Discover the overlooked SpaceX IPO strategy before the June listing
9/30/20242,070,000 shares $18.71 million +74.0%9.4%6 $9.04
9/15/20241,190,000 shares $11.51 million -4.0%5.4%3.5 $9.67
8/31/20241,240,000 shares $14.27 million -36.1%5.7%4.1 $11.51
8/15/20241,940,000 shares $23.47 million +16.9%8.8%6.4 $12.10
7/31/20241,660,000 shares $20.83 million +97.5%7.7%5.6 $12.55
7/15/2024840,700 shares $10.94 million +8.4%3.9%3.2 $13.01
6/30/2024775,600 shares $12.44 million +23.4%3.6%4.6 $16.04
6/15/2024628,800 shares $10.93 million +15.8%2.9%4.4 $17.38
5/31/2024542,900 shares $9.03 million -20.7%3.1%3.6 $16.63
5/15/2024684,400 shares $9.55 million -1.7%4.5%5.3 $13.96
4/30/2024696,200 shares $8.67 million -16.8%4.3%5.9 $12.45
4/15/2024836,400 shares $10.11 million +6.8%5.2%8.1 $12.09
3/31/2024783,500 shares $12.29 million +63.4%4.9%7.3 $15.68
3/15/2024479,500 shares $7.47 million +41.3%3.0%4.4 $15.57
2/29/2024339,400 shares $4.96 million -3.6%2.1%3.6 $14.62
2/15/2024352,000 shares $5.36 million +16.8%2.8%3.6 $15.22
1/31/2024301,500 shares $5.17 million No Change2.4%2.8 $17.14

LXEO Short Interest - Frequently Asked Questions

Short interest is the volume of Lexeo Therapeutics shares that have been sold short but have not yet been covered or closed out. As of May 29th, investors have sold 13,775,211 shares of LXEO short. 18.53% of Lexeo Therapeutics' shares are currently sold short. Learn More on Lexeo Therapeutics' current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. LXEO shares currently have a short interest ratio of 17.4. Learn More on Lexeo Therapeutics's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 18.53% of Lexeo Therapeutics' floating shares are currently sold short.

Lexeo Therapeutics saw a increase in short interest in the month of May. As of May 29th, there was short interest totaling 13,775,211 shares, an increase of 4.3% from the previous total of 13,212,896 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

18.53% of Lexeo Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Lexeo Therapeutics: Amylyx Pharmaceuticals, Inc. (15.10%), Precigen, Inc. (21.34%), Damora Therapeutics, Inc. Common Stock (2.29%), Inhibrx Biosciences, Inc. (26.51%), Vir Biotechnology, Inc. (11.19%), MBX Biosciences, Inc. (10.11%), Immatics N.V. (3.58%), Ardelyx, Inc. (10.59%), Immunocore Holdings PLC Sponsored ADR (19.20%), Hyperliquid Strategies Inc (6.03%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($81.27 billion), Invesco QQQ ($49.06 billion), iShares Russell 2000 ETF ($23.61 billion), Western Digital Corporation ($16.93 billion), Sandisk Corporation ($15.61 billion), Salesforce Inc. ($11.65 billion), SPDR S&P Biotech ETF ($10.52 billion), Nebius Group N.V. ($10.24 billion), Lumentum Holdings Inc. ($8.74 billion), and iShares iBoxx $ High Yield Corporate Bond ETF ($8.21 billion). View all of the most shorted stocks.

Short selling LXEO is an investing strategy that aims to generate trading profit from Lexeo Therapeutics as its price is falling. LXEO shares are trading up $0.03 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Lexeo Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of LXEO, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including LXEO, twice per month. The most recent reporting period available is May, 29 2026.

Understanding short interest metrics can help you assess how traders are positioning around a stock like LXEO:

  • Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.
  • Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.
  • Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.

These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity.


Related Companies
Short Interest Tools

This page (NASDAQ:LXEO) was last updated on 6/9/2026 by MarketBeat.com Staff.
From Our Partners
June 12: $100 Turns Into $100,000?
The SpaceX IPO is scheduled for June 12, and former tech executive Jeff Brown - who identified Bitcoin, Tesla,...
Brownstone Research | Sponsoredtc pixel
$30 stock to buy before Starlink goes public (WATCH NOW!)
In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...
Paradigm Press | Sponsoredtc pixel
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Your book attached
Your Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...
Profits Run | Sponsoredtc pixel
SpaceX just filed. The clock is ticking.
Reuters reports Elon Musk filed secretly. Barron's says it's being finalized behind closed doors. CNBC just re...
The Oxford Club | Sponsoredtc pixel
SpaceX will mint billionaires. You won't be one of them.
By the time a company goes public, 95% of profits have already been made. Insiders bought SpaceX at $20 billio...
Behind the Markets | Sponsoredtc pixel
Read now. Do not delete. You’ve been warned.
Three Nobel Prize Winners expose this once-in-a-generation wealth shift: “Don’t Say I Didn’t Warn You” P...
Porter & Company | Sponsoredtc pixel